CD4 and tuberculosis: Larger studies with longer patient follow-up are required to further assess relations and co-factors, understand why patients who are LAM positive at ART initiation have lower CD4 gains and determine if the inexpensive LAM test can be added to the HIV/TB armoury to improve treatment outcomes.